Lv0
0 积分 2025-12-02 加入
Structural basis of BAX pore formation
2个月前
已完结
Deciphering molecular specificity in MCL-1/BAK interaction and its implications for designing potent MCL-1 inhibitors
2个月前
已完结
Deciphering molecular specificity in MCL-1/BAK interaction and its implications for designing potent MCL-1 inhibitors
3个月前
已完结
The path to venetoclax resistance is paved with mutations, metabolism, and more
3个月前
已完结
The role of HRK gene in human cancer
3个月前
已完结
Lisaftoclax: First Approval
3个月前
已完结
Deciphering molecular specificity in MCL-1/BAK interaction and its implications for designing potent MCL-1 inhibitors
4个月前
已完结
How I treat patients with CLL after prior treatment with a covalent BTK inhibitor and a BCL-2 inhibitor
6个月前
已完结
Mutations and translocations associated with venetoclax resistance in chronic lymphocytic leukemia
6个月前
已完结
Ibrutinib lead-in followed by venetoclax plus ibrutinib for relapsed/refractory chronic lymphocytic leukemia: the SAKK 34/17 trial
6个月前
已完结
皖公网安备34019202002308
